Q1: 2026-05-07 Earnings Summary
EPS of -$0.30 beats by $0.14
|
Revenue of
$247.22M
(5.46% Y/Y)
beats by $6.71M
Tandem Diabetes Care, Inc. (TNDM) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDT
Company Participants
Susan Morrison - Executive VP & Chief Administrative Officer
John Sheridan - President, CEO & Director
Leigh Vosseller - Executive VP, CFO & Treasurer
Conference Call Participants
Matthew Miksic
Christopher Pasquale - Nephron Research LLC
Matthew O'Brien - Piper Sandler & Co., Research Division
Michael Kratky - Leerink Partners LLC, Research Division
David Roman - Goldman Sachs Group, Inc., Research Division
Richard Newitter - Truist Securities, Inc., Research Division
Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division
Matthew Taylor - Jefferies LLC, Research Division
Joanne Wuensch - Citigroup Inc., Research Division
Suraj Kalia - Oppenheimer & Co. Inc., Research Division
Larry Biegelsen - Wells Fargo Securities, LLC, Research Division
Michael Polark - Wolfe Research, LLC
Priya Sachdeva - UBS Investment Bank, Research Division
Jayson Bedford - Raymond James & Associates, Inc., Research Division
Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division
Anthony Petrone - Mizuho Securities USA LLC, Research Division
Mathew Blackman - TD Cowen, Research Division
William Plovanic - Canaccord Genuity Corp., Research Division
Travis Steed - BofA Securities, Research Division
Shagun Singh Chadha - RBC Capital Markets, Research Division
Presentation
Operator
Good day, and thank you for standing by. Welcome to the Tandem Diabetes Care First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Susan Morrison, Executive Vice President and Chief Administrative Officer. Ma'am, please go ahead.
Susan Morrison
Executive VP & Chief Administrative Officer
Hello, and welcome to Tandem's First Quarter 2026 Earnings Call. Today's discussion will include forward-looking statements. These statements reflect management's expectations about future events, our product pipeline, development time lines and financial performance and operating plans and speak only as of today's date. There are risks and uncertainties that could cause actual results to differ
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。